Bio-Rad Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,050	8,212	9,182	9,399	12,460	22,439
Market Cap Growth	28.32%	-10.57%	-2.31%	-24.57%	-44.47%	29.37%
Enterprise Value	7,863	8,189	8,948	9,046	11,989	21,328
Last Close Price	300.79	302.99	328.51	322.89	420.49	755.57
PE Ratio	48.19	10.81	-	-	-	5.28
Forward PE	33.53	28.94	28.85	26.51	28.66	59.87
PS Ratio	3.11	3.18	3.58	3.52	4.45	7.68
PB Ratio	1.18	1.10	1.40	1.08	1.30	1.64
P/TBV Ratio	1.32	1.23	1.57	1.17	1.40	1.72
P/FCF Ratio	22.54	21.92	31.71	43.08	152.70	41.88
P/OCF Ratio	15.77	15.43	20.17	25.07	64.10	33.52
PEG Ratio	-	2.21	2.21	2.21	2.21	2.21
EV/Sales Ratio	3.04	3.17	3.49	3.39	4.28	7.30
EV/EBITDA Ratio	17.68	18.97	20.30	17.68	19.34	30.37
EV/EBIT Ratio	28.43	30.76	30.94	24.74	24.84	37.77
EV/FCF Ratio	22.01	21.86	30.90	41.46	146.93	39.81
Debt / Equity Ratio	0.20	0.19	0.21	0.16	0.14	0.02
Debt / EBITDA Ratio	2.69	2.78	2.69	2.44	2.05	0.30
Debt / FCF Ratio	3.86	3.70	4.75	6.44	17.01	0.42
Net Debt / Equity Ratio	-0.03	-0.02	-0.04	-0.02	-0.04	-0.05
Net Debt / EBITDA Ratio	-0.42	-0.36	-0.66	-0.39	-0.65	-0.92
Net Debt / FCF Ratio	-0.52	-0.42	-1.00	-0.92	-4.93	-1.21
Asset Turnover	0.27	0.26	0.24	0.21	0.18	0.19
Inventory Turnover	1.59	1.65	1.52	1.65	1.91	2.11
Quick Ratio	2.19	3.89	4.55	4.03	4.04	1.90
Current Ratio	3.21	5.62	6.48	5.83	5.55	2.92
Return on Equity (ROE)	2.50%	10.84%	-24.09%	-6.94%	-31.14%	36.11%
Return on Assets (ROA)	1.79%	1.67%	1.67%	1.77%	1.93%	2.29%
Return on Invested Capital (ROIC)	3.01%	2.99%	3.90%	4.12%	4.34%	3.98%
Return on Capital Employed (ROCE)	3.10%	2.60%	3.30%	3.10%	3.70%	3.30%
Earnings Yield	2.10%	9.25%	-20.08%	-6.78%	-29.11%	18.96%
FCF Yield	4.44%	4.56%	3.15%	2.32%	0.66%	2.39%
Buyback Yield / Dilution	3.69%	3.31%	3.41%	1.93%	1.40%	-0.16%

SEC Filings: 10-K · 10-Q